0001236030-24-000015.txt : 20240510
0001236030-24-000015.hdr.sgml : 20240510
20240510090418
ACCESSION NUMBER: 0001236030-24-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240508
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson Robert Eugene
CENTRAL INDEX KEY: 0001511858
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 24933047
MAIL ADDRESS:
STREET 1: 245 N. HIGHLAND AVE NE
STREET 2: SUITE 230-296
CITY: ATLANTA
STATE: GA
ZIP: 30307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-05-08
0
0000725363
CEL SCI CORP
CVM
0001511858
Watson Robert Eugene
245 N. HIGHLAND AVE NE
SUITE 230-296
ATLANTA
GA
30307
1
0
0
0
0
Common Stock
2024-05-08
4
P
0
20000
1.39
A
24431
D
On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.
Robert Watson
2024-05-10